International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease

Author(s): McElhiney Linda F

Issue: May/Jun 2012 - Volume 16, Number 3
View All Articles in Issue

Page(s): 190-195

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 1

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 2

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 3

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 4

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 5

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 6

Download in electronic PDF format for $75

Abstract: Vital dyes have been used for over a hundred years to assist ophthalmic practitioners in diagnosing their patients’ problems. Patients don’t always tolerate the commercial products, usually due to the preservatives, and may need a compounded preparation. Some dyes are not commercially available, such as the brilliant blue G, and compounders who specialize in high-risk compounded sterile preparations are needed to meet these needs of the ophthalmologists. This article discusses some of these staining agents, including their properties.

Related Keywords: vital dyes, ophthalmic stains, ocular pathology, eye disorders, formulations, cornea lesions, corneal abrasions, keratitis, preservatives, compounded sterile preparations, microbial contamination, ophthalmic solutions, fluorescein, rose bengal, dry eye, keratoconjunctivitis sicca, lissamine green B, brilliant blue G, intravitreal administration

Related Categories: FORMULATIONS, OPHTHALMICS, STERILE PREPARATIONS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease McElhiney Linda F	May/Jun 2012 Pg. 190-195
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Allen Loyd V Jr	Sep/Oct 2016 Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Allen Loyd V Jr	Nov/Dec 2016 Pg. 495-500
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Mixon William, Angelle Patricea (Patsy), Chang Richard I	Nov/Dec 2009 Pg. 506-515
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Davidson Gigi S	Jul/Aug 2004 Pg. 277-283
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 Davidson Gigi S	May/Jun 2004 Pg. 169-172
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 Davidson Gigi S	Sep/Oct 2004 Pg. 359-367
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2010 Pg. 421
Compounding for Feline Herpetic Keratitis Davidson Gigi S	Nov/Dec 2006 Pg. 411-414
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Kochanowska-Karamyan Anna J	Sep/Oct 2016 Pg. 367-374
Infliximab 1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2017 Pg. 62
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Allen Loyd V Jr	May/Jun 2019 Pg. 221-228
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Allen Loyd V Jr	Nov/Dec 2015 Pg. 508
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H	Sep/Oct 2014 Pg. 418-426
Atropine Sulfate 1% Ophthalmic Solution Allen Loyd V Jr	May/Jun 2015 Pg. 242
Cleaning of Isolators: A Vital Part of a Contamination Control Program Rossington Karen	Nov/Dec 2004 Pg. 452-456
Treating Canine Hepatic Disease Davidson Gigi S	May/Jun 2003 Pg. 188-191
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Davidson Michael G	Mar/Apr 2001 Pg. 92-94
Return to Top